Omne Possibile

Omne Possibile

closed

Develops new-to-nature nucleic acids (XNA) to safely control and program the genetic makeup of biological organisms.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round
*

N/A

Seed
Total Funding000k
Notes (0)
More about Omne Possibile
Made with AI
Edit

Omne Possibile is a pioneering company in the field of synthetic biology, leveraging the transformative potential of XNA (xeno nucleic acids) to revolutionize various industries. The company operates in the medicine, agriculture, information technology, and consumer products sectors. Omne Possibile's business model focuses on developing two main product lines: advanced data storage solutions and therapeutic messengers. These products cater to a diverse range of clients, including pharmaceutical companies, agricultural firms, IT enterprises, and consumer goods manufacturers. The company generates revenue through the sale of its innovative products and potential licensing agreements. Omne Possibile's strategic locations in Leuven, Belgium, and Basel, Switzerland, position it at the heart of Europe's biotech and innovation hubs.

Keywords: XNA, synthetic biology, data storage, therapeutic messengers, medicine, agriculture, IT, consumer products, biotech, innovation.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads